PBRM1 (encoding BAF180 protein) is found to be mutated in 2%–10% of bladder tumours, and it exerts a suppressive effect on bladder cancer by inhibiting the activity of cyclin B [36]. This evidence concerns the gene PBRM1 and urinary bladder cancer.